Vladimir EgorovVladimir Egorov, PhD, is the CEO of Advanced Tactile Imaging, a medical device developer and manufacturer whose primary area of focus is women’s healthcare including pelvic organ prolapse, stress urinary incontinence, vaginal tissue atrophy, overactie bladder, spontaneous preterm delivery, and maternal birth trauma. Dr. Egorov participated in 13 R&D projects—funded by National Institutes of Health (NIH) and Department of Defense (DoD)—related to medical devices from a feasibility study to production in FDA-audited environment and commercialization. He led the six of them as a Principal Investigator. His team developed a series of innovative devices for biomechanical charaterization of the female pelvic floor.

Dr. Egorov received his MS in Biophysics from the Moscow Institute of Physics and Technology, USSR, and was granted a PhD in Biology, working at the Institute of Basic Biological Problems, Pushchino. He has over 30 years of experience in hardware, software, algorithm development and statistical data analysis, regulatory compliance and approvals (FDA, CE, TGA), and clinical studies (feasibility, development, validation). Dr. Egorov has 81 peer-reviewed research publications (78 journals and 3 book chapters) related to different aspects of academic research, instrumentation, and clinical applications. He coauthored 29 issued patents, most of them disclosing the specific details of tactile imaging technology in medical applications. Read More Read Less